Related Experiment Video
Updated: Aug 18, 2026

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
Published on: June 10, 2025
Terbinafine-induced subacute cutaneous lupus erythematosus
David A McKay1, Olivia M V Schofield, E Claire Benton
1Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh, UK. david.mckay@ed.ac.uk
Abstract:
Oral terbinafine is licensed for use in onychomycosis after positive confirmation of infection. We describe five cases of subacute cutaneous lupus erythematosus associated with terbinafine therapy. All cases had positive antibodies to extractable nuclear antigens, predominantly anti-Ro, and several had a history of pre-existing autoimmune disease. Terbinafine should only be prescribed after confirmation of infection by microscopy or culture.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Diabetic Foot Ulcer
Antifungal Agents
Acne Infection
